BACKGROUND: Persons living with HIV are at a higher risk of cardiovascular disease despite effective antiretroviral therapy and dramatic reductions in AIDS-related conditions. We sought to identify the epidemiology of heart failure (HF) among persons living with HIV in the United States in an era of contemporary antiretroviral therapy. METHODS: Explorys is an electronic healthcare database that aggregates medical records from 23 healthcare systems nationwide. Using systemized nomenclature of medicine-clinical terms (SNOMED-CT), we identified adult patients (age>18), who had active records over the past year (September 2014-September 2015). We described the prevalence of HF in HIV patients by demographics and treatment and compared them to HIV-uninfected controls. RESULTS: Overall, there were 36,400 patients with HIV and 12,208,430 controls. The overall prevalence of HF was 7.2% in HIV and 4.4% in controls (RR 1.66 [1.60-1.72], p<0.0001). The relative risk of HF associated with HIV infection was higher among women and younger age groups. Patients receiving antiretroviral therapy had only marginally lower risk (6.4% vs. 7.7%, p<0.0001) of HF compared to those who were untreated. Compared to uninfected patients with HF, HIV patients with HF were less likely to receive antiplatelet drugs, statins, diuretics, and ACE/ARBs (p<0.0001 for all comparisons). For patients with HIV and HF, receiving care from a cardiologist was associated with higher use of antiplatelets, statins, betablockers, ACE/ARBs, and diuretics. CONCLUSIONS: Persons with HIV are at higher risk for HF in this large contemporary sample that includes both men and women. Although the prevalence of heart failure is higher in older HIV patients, the relative risk associated with HIV is highest in young people and in women. HIV patients are less likely to have HF optimally treated, but cardiology referral was associated with higher treatment rates.
BACKGROUND:Persons living with HIV are at a higher risk of cardiovascular disease despite effective antiretroviral therapy and dramatic reductions in AIDS-related conditions. We sought to identify the epidemiology of heart failure (HF) among persons living with HIV in the United States in an era of contemporary antiretroviral therapy. METHODS: Explorys is an electronic healthcare database that aggregates medical records from 23 healthcare systems nationwide. Using systemized nomenclature of medicine-clinical terms (SNOMED-CT), we identified adult patients (age>18), who had active records over the past year (September 2014-September 2015). We described the prevalence of HF in HIVpatients by demographics and treatment and compared them to HIV-uninfected controls. RESULTS: Overall, there were 36,400 patients with HIV and 12,208,430 controls. The overall prevalence of HF was 7.2% in HIV and 4.4% in controls (RR 1.66 [1.60-1.72], p<0.0001). The relative risk of HF associated with HIV infection was higher among women and younger age groups. Patients receiving antiretroviral therapy had only marginally lower risk (6.4% vs. 7.7%, p<0.0001) of HF compared to those who were untreated. Compared to uninfected patients with HF, HIVpatients with HF were less likely to receive antiplatelet drugs, statins, diuretics, and ACE/ARBs (p<0.0001 for all comparisons). For patients with HIV and HF, receiving care from a cardiologist was associated with higher use of antiplatelets, statins, betablockers, ACE/ARBs, and diuretics. CONCLUSIONS:Persons with HIV are at higher risk for HF in this large contemporary sample that includes both men and women. Although the prevalence of heart failure is higher in older HIVpatients, the relative risk associated with HIV is highest in young people and in women. HIVpatients are less likely to have HF optimally treated, but cardiology referral was associated with higher treatment rates.
Authors: Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg Journal: Arch Intern Med Date: 2011-04-25
Authors: Victoria K Shanmugam; Stephen J Fernandez; Karen Kim Evans; Sean McNish; Anirban N Banerjee; Kara S Couch; Mihriye Mete; Nawar Shara Journal: Wound Repair Regen Date: 2015 Mar-Apr Impact factor: 3.617
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Matthew S Freiberg; David A Leaf; Joseph L Goulet; Matthew B Goetz; Krisann K Oursler; Cynthia L Gibert; Maria C Rodriguez-Barradas; Adeel A Butt; Amy C Justice Journal: J Gen Intern Med Date: 2009-01-06 Impact factor: 5.128
Authors: Keri N Althoff; Kathleen A McGinnis; Christina M Wyatt; Matthew S Freiberg; Cynthia Gilbert; Krisann K Oursler; David Rimland; Maria C Rodriguez-Barradas; Robert Dubrow; Lesley S Park; Melissa Skanderson; Meredith S Shiels; Stephen J Gange; Kelly A Gebo; Amy C Justice Journal: Clin Infect Dis Date: 2014-10-30 Impact factor: 9.079
Authors: Julie A Womack; Chung-Chou H Chang; Kaku A So-Armah; Charles Alcorn; Jason V Baker; Sheldon T Brown; Matthew Budoff; Adeel A Butt; Cynthia Gibert; Matthew Bidwell Goetz; John Gottdiener; Stephen Gottlieb; Amy C Justice; David Leaf; Kathleen McGinnis; David Rimland; Maria C Rodriguez-Barradas; Jason Sico; Melissa Skanderson; Hilary Tindle; Russell P Tracy; Alberta Warner; Matthew S Freiberg Journal: J Am Heart Assoc Date: 2014-10-16 Impact factor: 5.501
Authors: Matthew J Feinstein; Milana Bogorodskaya; Gerald S Bloomfield; Rajesh Vedanthan; Mark J Siedner; Gene F Kwan; Christopher T Longenecker Journal: Curr Cardiol Rep Date: 2016-11 Impact factor: 2.931
Authors: Jonathan Buggey; Leo Yun; Chung-Lieh Hung; Cissy Kityo; Grace Mirembe; Geoffrey Erem; Tiffany Truong; Isaac Ssinabulya; W H Wilson Tang; Brian D Hoit; Grace A McComsey; Chris T Longenecker Journal: Heart Date: 2019-09-19 Impact factor: 5.994
Authors: Alexandra B Steverson; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Jes M Sanders; Chad J Achenbach; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein Journal: Eur J Prev Cardiol Date: 2017-09-25 Impact factor: 7.804
Authors: Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Olga V Patterson; Scott L DuVall; Cynthia A Brandt; Kaku A So-Armah; Ramachandran S Vasan; Kris Ann Oursler; John Gottdiener; Stephen Gottlieb; David Leaf; Maria Rodriguez-Barradas; Russell P Tracy; Cynthia L Gibert; David Rimland; Roger J Bedimo; Sheldon T Brown; Matthew Bidwell Goetz; Alberta Warner; Kristina Crothers; Hilary A Tindle; Charles Alcorn; Justin M Bachmann; Amy C Justice; Adeel A Butt Journal: JAMA Cardiol Date: 2017-05-01 Impact factor: 14.676
Authors: Shelli L Feder; Janet P Tate; Kathleen M Akgün; Julie A Womack; Sangchoon Jeon; Marjorie Funk; Roger J Bedimo; Matthew J Budoff; Adeel A Butt; Kristina Crothers; Nancy S Redeker Journal: Am J Hosp Palliat Care Date: 2018-10-10 Impact factor: 2.500